Our PDT experience in the treatment of non-melanoma skin cancer over the last 7 years

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 6, 2006, Pages 693-697

  Baptista, J ^a   Martinez, C ^a   Leite, L ^a   Cochito, M ^a  

^a Hospital do Desterro   (Portugal)

Author keywords

5 aminolevulinic acid; Actinic keratoses; Basal cell carcinoma; Non melanoma skin cancer; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID;

ACTINIC POROKERATOSIS; ADULT; AGED; ARTICLE; BURNING SENSATION; CANCER LOCALIZATION; CONTROLLED STUDY; DEVICE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; MAJOR CLINICAL STUDY; MALE; PAGET NIPPLE DISEASE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN BIOPSY; SKIN CANCER; SKIN SURFACE; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WOUND HEALING;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 33745280935     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01574.x     Document Type: Article

References (18)

1. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience. J Photochem Photobiol B 1990; 6: 143-148.
2. Henderson BW, Waldow SM, Mang TS, Potter WR, Malone PB, Dougherty TJ. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res 1985; 45: 572-576.
3. Zalar GL, Poh-Fitzpatrick M, Krohn DL, Jacobs R, Harber LC. Induction of drug photosensitization in man after parenteral exposure to hematoporphyrin. Arch Dermatol 1977; 113: 1392-1397.
4. Wolf P, Rieger E, Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid: An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas and basal cell carcinoma. J Am Acad Dermatol 1993; 28: 17-21.
5. Lui H. Photodynamic therapy: When will the promise be kept? Med Surg Dermatol 1996; 3: 137-139.
6. Antoniou C, Katsambas A, Rigopoulos D, Palaskas E, Tsikrikas GN. Aminolevulinic acid - topical photodynamic therapy in skin cancers and solar keratoses. Skin Cancer 1996; 11: 81-84.
7. Wilson BD, Mang TS, Stoll H et al. Photodynamic therapy for the treatment of basal cell carcinoma. Arch Dermatol 1992; 128: 1597-1601.
8. Jones C, Mang T, Cooper M, Wilson BD, Stoll HL. Photodynamic therapy in the treatment of Bowen's disease. J Am Acad Dermatol 1992; 27: 979-982.
9. Alvanopoulos K, Antoniou C, Melpo P, Vareltzidis A, Katsambas A. Photodynamic therapy of superficial basal cell carcinomas using exogenous 5-aminolevulinic acid and 514 nm light. J Europ Acad Dermatol Venereol 1997; 9: 134-136.
10. Jeffes EW, McCullough JL, Weinstein GD et al. Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid: A pilot dose-ranging study. Arch Dermatol 1997; 133: 727-732.
11. Salim A, Leman JA, McColl JH, Chapman R, Morton CA. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol 2003; 148: 539-543.
12. Morton CA, Brown SB, Collins S et al. Guidelines for topical photodynamic therapy: Report of a workshop of the British photodermatology group. Br J Dermatol 2002; 146: 552-567.
13. Kormeili T, Yamauchi PS, Lowe NJ. Topical photodynamic therapy in clinical dermatology. Br J Dermatol 2004; 150: 1061-1069.
14. Taub AF. Photodynamic therapy in dermatology: History and horizons. J Drugs Dermatol 2004; 3: S8-S25.
15. Choudry K, Brooke RCC, Farrar W, Rhodes LE. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolevulinic acid photodynamic therapy. Br J Dermatol 2003; 149: 124-130.
16. Palsson S, Gustafsson L, Bendsoe N, Thompson MS, Andersson-Engels S, Svanberg K. Kinetics of the superficial perfusion and temperature in connection with photodynamic therapy of basal cell carcinomas using esterified and non-esterified 5-aminolevulinic acid. Br J Dermatol 2003; 148: 1179-1188.
17. Bissonnette R, Sharfaei S, Viau G, Liu Y. Irradiance and light dose influence histological localization of photodamage induced by photodynamic therapy with aminolevulinic acid. Br J Dermatol 2004; 151: 653-655.
18. Tsai J-C, Chen I-H, Wong T-W, Lo Y-L. In vitro/in vivo correlations betwen transdermal delivery of 5-aminolevulinic acid and cutaneous protoporphyrin IX accumulation and effect of formulation. Br J Dermatol 2002; 146: 853-862.